Private Wealth Asset Management, LLC Neurocrine Biosciences Inc Put Options Transaction History
Private Wealth Asset Management, LLC
- $695 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
651Shares Held
96.5MCall Options Held
702KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$666 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$585 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$321 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...